Stock price
$21.42
July 6th
Used to calculate 14% dividend yield.
Exego Fair Value
$17.3 million
Q1 FY27
Represents 70 cents of its total cost; on red watch list.
NAV per share
$23.23down from $24.42 last quarter and $25.52 last year
Q1 FY27
Sequential quarter reduction of $1.19, with 28 cents (24%) due to under-earning the dividend.
Adjusted NII per share
47 centsdown 11.3% from last quarter and 28.8% from last year
Q1 FY27
Reflects impact of lower short-term interest rates and tightening spreads, and changes to capital structure.
Adjusted NII yield
7.8%down from 8.4% last quarter and 10.3% last year
Q1 FY27
Reflects impact of lower short-term interest rates and tightening spreads, and changes to capital structure.
Latest 12 months Return on Equity (ROE)
4%down from 9.1% last quarter and 9.3% last year
LTM
Above BDC industry average of 2.4%.
Long-term average ROE (12 years)
10.1%
LTM
Well above BDC industry average of 6.7%.
Credit Quality (highest category)
98.3%
Q1 FY27
Percentage of credits rated in the highest category.
Non-accrual investments (fair value)
0.0%
Q1 FY27
Represents Pepper Palace and CLO's F note.
Non-accrual investments (cost)
1.2%
Q1 FY27
Represents Pepper Palace and CLO's F note, well below industry average of 3.7%.
Public Baby Bond Interest Rate
7.5%
Q4 FY26
Interest rate on $100 million public baby bond issued last quarter.
Private Note Interest Rate
7.25%
Q1 FY27
Interest rate on $25 million private note issued during the quarter.
Institutional Bond Repaid
$175 million
Q4 FY26
Repaid at end of February.
Total Expenses (excl. interest, fees, taxes)
$2.7 milliondown from $2.8 million last year and up from $2.4 million last quarter
Q1 FY27
Represents 0.9% of average total assets on an annualized basis.
Total Expenses (as % of average total assets)
0.9%up from 0.8% last quarter and last year
Q1 FY27
Annualized basis.
NAV decrease (YoY)
$17.9 million
Q1 FY27
Decrease from last year.
NAV decrease (QoQ)
$17.7 million
Q1 FY27
Decrease from last quarter.
First Lien Loans (software portfolio LTV)
37%
Q1 FY27
Loan-to-value for software portfolio.
First Lien Loans (software portfolio composition)
89%
Q1 FY27
Percentage of first lien loans in software portfolio.
Equity Securities (software portfolio composition)
5.7%
Q1 FY27
Percentage of equity securities in software portfolio.
Overall Portfolio Fair Value vs. Cost
0.9% below cost
Q1 FY27
Fair value of overall portfolio relative to cost.
Net Positive Originations
$31 million
Q1 FY27
Resulting from $79 million new originations and $11 million CLO debt investments, offsetting repayments.
AUM Growth
1.6%
Q1 FY27
Growth during the quarter.
Core BDC Portfolio Fair Value vs. Cost
0.2% below cost
Q1 FY27
Fair value of core BDC portfolio relative to cost.
Total Portfolio Valuation vs. Cost
3.6% below cost
Q1 FY27
Total portfolio valuation relative to cost.
Core BDC Net Interest Margin
$13.4 millionup from $13 million last quarter
Q1 FY27
Driven by 4.8% increase in average core assets, partially offset by 5 bps decrease in average SOFR.
Average Core Assets Growth
4.8%
Q1 FY27
Increase in average core assets.
Average SOFR Rate Decrease
5 bps
Q1 FY27
Decrease in average SOFR rate used in the portfolio.
Origination Spreads vs. Repayment Spreads
almost 50 basis points lower
Q1 FY27
Spreads on originations this quarter compared to repayments.
Investment Capacity
$197 million
Q1 FY27
Total available investment capacity.
SBIC III License Capacity
$46 million
Q1 FY27
Available from existing SBIC III license.
Revolving Credit Facilities Capacity
$90 million
Q1 FY27
Available from two revolving credit facilities.
Cash Available
$61 million
Q1 FY27
Cash at quarter end.
Weighted Average Common Shares Outstanding
16.3 millionincreasing from 16.2 million last quarter and 15.3 million last year
Q1 FY27
Weighted Average Interest Rate (Core BDC Portfolio)
10.5%compared to 11.5% last year and 10.4% last quarter
Q1 FY27
Yield reduction from last year reflects SOFR decreases and tighter spreads on new originations.
CLO Yield
11.0%decreased from 11.6% last quarter
Q1 FY27
Due to higher fair value in Q1.
Equity Interests (portfolio composition)
7.2%
Q1 FY27
Percentage of investment portfolio consisting of equity interests.
Net Realized Gain (Equity Interests)
$0.2 million
Q1 FY27
Generated during the first quarter.
Total Net Realized Gain (Equity Interests, 14 fiscal years)
$45.5 million
LTM
Combined net realized gain from sale of equity interests.
New Platform Companies (last year)
11
LTM
Total new platform companies closed.
First Lien Debt (portfolio composition)
81.7%
Q1 FY27
Percentage of total investments in first lien debt.
First Lien Last Out Positions (portfolio composition)
19.0%
Q1 FY27
Percentage of first lien debt in first lien last out positions.
Total Leverage (overall portfolio)
4.8 times
Q1 FY27
Excluding Pepper Palace, reflecting new investments at lower leverage levels.
Term Sheets Issued (last 12 months)
107
LTM
Origination Total (fiscal quarter)
$79.2 million
Q1 FY27
Consisting of two new investments, 10 follow-ons, and six BBB and BBB CLO debt investments.
Realized Economic Losses (since management team began)
3
since 2010
On 132 portfolio companies.
Exited Investments (since management team began)
88
since 2010
Achieving gross unlevered realized returns of 14.9% on $1.37 billion of realizations.
Combined Unleveled Realized and Unrealized Returns
13.3%
since 2010
On all capital invested.
Dividend Declared
75 cents per share
Q2 FY27
Declared for the quarter ended August 31, 2026.
Total Return (last 12 months)
6%outperforming BDC index's negative 13%
LTM
Includes both capital appreciation and dividends, places in top five of all BDCs.
Total Return (since 2010)
871%more than three times the industry's 250%
since 2010
Management Ownership
11%
Q1 FY27
One of the highest levels in the industry.
Spillover Income
$1.75 per share
May 31, 2026
Spillover income as of May 31st.
Spillover Income (current)
$1.50 per share
July 8, 2026
Spillover income at the time of the call, after a dividend payment.
Available Capital (non-regulatory leverage impacting)
$100 million
Q1 FY27
Composed of cash and SBIC debentures, does not count towards regulatory leverage.